Boyero Laura, Martin-Padron Joel, Fárez-Vidal María Esther, Rodriguez Maria Isabel, Andrades Álvaro, Peinado Paola, Arenas Alberto M, Ritoré-Salazar Félix, Alvarez-Perez Juan Carlos, Cuadros Marta, Medina Pedro P
Pfizer-University of Granada-Junta de Andalucía Centre for Genomics and Oncological Research (GENYO), Granada, Spain.
Department of Biochemistry and Molecular Biology III, University of Granada, Granada, Spain.
Cell Oncol (Dordr). 2022 Apr;45(2):323-332. doi: 10.1007/s13402-022-00660-1. Epub 2022 Feb 19.
Plakophilin 1 (PKP1) is well-known as an important component of the desmosome, a cell structure specialized in spot-like cell-to-cell adhesion. Although desmosomes have generally been associated with tumor suppressor functions, we recently found that PKP1 is recurrently overexpressed in squamous cell lung cancer (SqCLC) to exert an oncogenic role by enhancing the translation of MYC (c-Myc), a major oncogene. In this study, we aim to further characterize the functional relationship between PKP1 and MYC.
To determine the functional relationship between PKP1 and MYC, we performed correlation analyses between PKP1 and MYC mRNA expression levels, gain/loss of function models, chromatin immunoprecipitation (ChIP) and promoter mutagenesis followed by luciferase assays.
We found a significant correlation between the mRNA levels of MYC and PKP1 in SqCLC primary tumor samples. In addition, we found that MYC is a direct transcription factor of PKP1 and binds to specific sequences within its promoter. In agreement with this, we found that MYC knockdown reduced PKP1 protein expression in different SqCLC models, which may explain the PKP1-MYC correlation that we found. Conversely, we found that PKP1 knockdown reduced MYC protein expression, while PKP1 overexpression enhanced MYC expression in these models.
Based on these results, we propose a feedforward functional relationship in which PKP1 enhances MYC translation in conjunction with the translation initiation complex by binding to the 5'-UTR of MYC mRNA, whereas MYC promotes PKP1 transcription by binding to its promoter. These results suggest that PKP1 may serve as a therapeutic target for SqCLC.
桥粒斑蛋白1(PKP1)是桥粒的重要组成部分,桥粒是一种专门负责点状细胞间黏附的细胞结构。尽管桥粒通常与肿瘤抑制功能相关,但我们最近发现PKP1在肺鳞状细胞癌(SqCLC)中反复过度表达,通过增强主要癌基因MYC(c-Myc)的翻译发挥致癌作用。在本研究中,我们旨在进一步阐明PKP1与MYC之间的功能关系。
为了确定PKP1与MYC之间的功能关系,我们进行了PKP1与MYC mRNA表达水平的相关性分析、功能获得/缺失模型、染色质免疫沉淀(ChIP)以及启动子诱变后的荧光素酶测定。
我们在SqCLC原发性肿瘤样本中发现MYC和PKP1的mRNA水平之间存在显著相关性。此外,我们发现MYC是PKP1的直接转录因子,并与其启动子内的特定序列结合。与此一致,我们发现在不同的SqCLC模型中,MYC敲低降低了PKP1蛋白表达,这可能解释了我们发现的PKP1-MYC相关性。相反,我们发现在这些模型中,PKP1敲低降低了MYC蛋白表达,而PKP1过表达增强了MYC表达。
基于这些结果,我们提出了一种前馈功能关系,即PKP1通过与MYC mRNA 的5'-UTR结合,与翻译起始复合物共同增强MYC翻译,而MYC通过与其启动子结合促进PKP1转录。这些结果表明PKP1可能是SqCLC的治疗靶点。